Background The standart surgical treatment of meningiomas is total resectio
n of the tumour. The complete removal of skull base meningiomas can be diff
icult because of the proximity of cranial nerves. Stereotactic radiosurgery
(SRS) is an effective therapy, either for adjuvant treatment in case of su
btotal or partial tumour resection, or as solitary treatment in asymptomati
c meningiomas.
Method. Between September 1992 and October 1995, SRS using the Leksell Gamm
a Knife was performed on 46 patients (f:m = 35: 15), ranging in age from 35
to 81 years, with skull base meningiomas at the Neurosurgical Department o
f the University of Vienna. According to the indication of gamma knife radi
osurgery (GKRS) the patients (n = 46) were devided into two subgroups. Grou
p I (combined procedure: subtotal resection followed by GKRS as a planned p
rocedure or because of a recurrent meningioma), group II (GKRS as the prima
ry treatment). Histological examination of tumour tissue was available for
31 patients (67%) after surgery covering 25 benign (81%) and 6 malignant (1
9%) meningioma subtypes.
Findings. The overall tumour control rate after a mean follow-up period of
48 months (ranging from 36 to 76 months) was 96% (97.5% in benign and 53% i
n malignant meningiomas). Group I displayed a 96.7% tumour control rate, fo
llowed by group TI with 93.3% respectively. Neurological follow-up showed a
n improvement in 33%, stable clinical course in 58% and a persistant deteri
oration of clinical symtoms in 9%. Remarkable neurological improvement afte
r GKRS was observed in group II (47%), whereas in group I (26%) the amelior
ation of symptoms was less pronounced.
Interpretation. GKRS in meningiomas is a safe and effective treatment. A go
od tumour control and low morbidity rate was achieved in both groups (I, II
) of our series, either as a primary or adjunctive therapeutic approach. Th
e planned combination of microsurgery and GKRS extends the therapeutic spec
trum in the treatment of meningiomas. Reduction of tumour volume, increasin
g the distance to the optical pathways and the knowledge of the actual grow
ing tendency by histological evaluation of the tumour minimises the risk of
morbidity and local regrowth. Small and sharply demarcated tumours are in
general ideal candidates for single high dose-GKRS, even after failed surge
ry and radiation therapy, and in special cases also in larger tumour sizes
with an adapted/reduced margine dose.